Mitroflow aortic pericardial bioprosthesis - clinical performance

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 5, 2009, Pages 818-824

  Jamieson, William Robert Eric ^a   Koerfer, Reiner ^b   Yankah, Charles A ^c   Zittermann, Armin ^b   Hayden, Robert I ^a   Ling, Hilton ^a   Hetzer, Roland ^c   Dolman, William B ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d CarboMedics Inc   (United States)

Author keywords

Aortic valve replacement; Bioprosthesis; Heart valve; Prosthesis

Indexed keywords

ADULT; AGED; AORTA PROSTHESIS; AORTA VALVE DISEASE; ARTICLE; BIOPROSTHESIS; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PERICARDIAL AORTIC BIOPROSTHESIS; PREDICTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 70349974426     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.05.020     Document Type: Article

References (25)

1. Pomar J.L., Jamieson W.R., Pelletier L.C., Gerein A.N., Castella M., and Brownlee R.T. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg 60 2 Suppl. (1995) S305 9, discussion S309-10
2. Pomar J.L., Jamieson W.R., Pelletier L.C., Castella M., Germann E., and Brownlee R.T. Mitroflow pericardial bioprosthesis experience in aortic valve replacement > or =60 years of age. Ann Thorac Surg 66 6 Suppl. (1998) S53-S56
3. Minami K., Zittermann A., Schulte-Eistrup S., Koertke H., and Korfer R. Mitroflow Synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 80 5 (2005) 1699-1705
4. Sjogren J., Gudbjartsson T., and Thulin L.I. Long-term outcome of the Mitroflow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valve Dis 15 2 (2006) 197-202
5. Yankah C.A., Schubel J., Buz S., Siniawski H., and Hetzer R. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position. J Heart Valve Dis 14 2 (2005) 172 9, discussion 179-80
6. Yankah C.A., Pasic M., Musci M., Stein J., Detschades C., Siniawski H., and Hetzer R. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg 136 3 (2008) 688-696
7. Benhameid O., Jamieson W.R.E., Castella M., Carrier M., Pomar J.L., Germann E., Pellerin M., and Brownlee R.T. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years. Thorac Cardiovasc Surg 58 (2008) 1-5
8. Garcia-Bengochea J., Sierra J., Gonzalez-Juanatey J., Rubio J., Vega M., Fernandez A., and Sanchez D. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A Pericardial Bioprosthesis. J Heart Valve Dis 15 (2006) 446-452
9. Jamieson WRE, Forgie WR, Hayden RI, Langlois Y, Ling H, Stanford EA, Roberts KA, Dolman WB. Mitroflow aortic pericardial bioprosthesis hemodynamic performance - optimizing management for the small aortic annulus. Thorac Cardioavasc Surgeon, submitted for publication.
10. Jamieson W.R., Burr L.H., Miyagishima R.T., Germann E., Macnab J.S., Stanford E., Chan F., Janusz M.T., and Ling H. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years. J Thorac Cardiovasc Surg 130 4 (2005) 994-1000
11. Jamieson W.R.E., Moffatt-Bruce S.D., Skarsgard P., Hadi M.A., Ye J., Fradet G.J., Abel J.G., Janusz M.T., Cheung A., and Germann E. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?. Ann Thorac Surg 83 2 (2007) 549-556
12. Gonzalez-Juanatey J., Garcia-Bengoechea J., and Garcia-Acuna J. The influence of the design on the medium to long term hemodynamic behavior of 19 mm pericardial aortic valve prostheses. J Heart Valve Dis 5 Suppl. III (1996) S284-S288
13. PC pericardial bioprosthesis in aortic valve replacement (Abstract). Can J Cardiol 17 c (2001) 198c
14. Summary of Safety and Effectiveness Data. Mitroflow Aortic Pericardial Heart Valve. CarboMedics Inc. (Pre-Market Approval - Investigational Device Exemption Document, Food & Drug Administration of the United States); 2007.
15. Leva C, Lazzarini I, Gallorini C, Vittonati L, Rizzo L, Di Credico G. Mitroflow supra-annular pericardial bioprosthesis in small aortic annulus: hemodynamic and clinical findings. Our Experience. XXIII Italian Society for Cardiac Surgery (Abstract); 2006.
16. Pibarot P., and Dumesnil J.G. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 36 4 (2000) 1131-1141
17. Wu Y.X., Takkenberg J.J.M., and Grunkemeier G.L. Measuring follow-up completeness. Ann Thor Surg 85 (2008) 1155-1157
18. Akins C.W., Miller D.C., Turina M.I., Kouchoukos N.T., Blackstone E.H., Grunkemeier G.L., Takkenberg J.J., David T.E., Butchart E.G., Adams D.H., Shahian D.M., Hagl S., Mayer J.E., and Lytle B.W. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 135 4 (2008) 732-738
19. Edmunds Jr. L.H., Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., and Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad hoc liaison committee for standardizing definitions of prosthetic heart valve morbidity of the American Association for Thoracic Surgery and the Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 112 3 (1996) 708-711
20. Grunkemeier G.L., Jamieson W.R.E., Miller D.C., and Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 108 4 (1994) 709-718
21. Frater R.W., Furlong P., Cosgrove D.M., Okies J.E., Colburn L.Q., Katz A.S., Lowe N.L., and Ryba E.A. Long-term durability and patient functional status of the Carpentier-Edwards PERIMOUNT pericardial bioprosthesis in the aortic position. J Heart Valve Dis 7 1 (1998) 48-53
22. Aupart M.R., Mirza A., Meurisse Y.A., Sirinelli A.L., Neville P.H., and Marchand M.A. PERIMOUNT pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J Heart Valve Dis 15 6 (2006) 768 75, discussion 775-6
23. Borger M.A., Ivanov J., Armstrong S., Christie-Hrybinsky D., Feindel C.M., and David T.E. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 15 1 (2006) 4955 discussion 55-6
24. Myken P.S. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 137 (2009) 76-81
25. Roselli E.E., Smedira N.G., and Blackstone E.H. Failure modes of the Carpentier-Edwards pericardial bioprosthesis in the aortic position. J Heart Valve Dis 15 May (3) (2006) 4217 discussion 427-8